896755007: Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Trastuzumab emtansine\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Product containing trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab emtansine (medicinal product)\Product containing trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Product containing trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Product containing trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Product containing trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab emtansine (medicinal product)\Trastuzumab emtansine\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)
\Medicinal product\Product manufactured as parenteral dose form\Product containing trastuzumab emtansine in parenteral dose form (medicinal product form)\Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

4029087016 Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

4029088014 Trastuzumab emtansine only product in parenteral dose form en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Has manufactured dose form	Parenteral dose form	true	Inferred relationship	Existential restriction modifier
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Is a	Trastuzumab emtansine	true	Inferred relationship	Existential restriction modifier
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Is a	Product containing trastuzumab emtansine in parenteral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Is a	Product containing only trastuzumab in parenteral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Count of base of active ingredient	1	false	Inferred relationship	Existential restriction modifier
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Has active ingredient	Trastuzumab emtansine	true	Inferred relationship	Existential restriction modifier	1

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Is a	False	Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Is a	False	Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Is a	False	Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Is a	False	Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	Is a	True	Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	Is a	True	Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4029087016	Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
4029088014	Trastuzumab emtansine only product in parenteral dose form	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module